Catalyst Wire Dossier Catalyst Wire Dossier

Ecallantide

ecallantide · Cubist Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.)
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Ecallantide, covering 2012-12-28 to 2021-05-18. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema [Phase 2, Phase 3]

See pricing